Company Analysis Exelixis
1. Summary
Advantages
- The stock's return over the last year (40.16%) is higher than the sector average (-15.96%).
Disadvantages
- Price (20.1 $) is higher than fair price (6.81 $)
- Dividends (0%) are below the sector average (0.5442%).
- Current debt level 6.46% has increased over 5 years from 2.68%.
- The company's current efficiency (ROE=9.18%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Exelixis | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.4% | -16.8% | -0.8% |
| 90 days | 28.9% | -20.8% | 9% |
| 1 year | 40.2% | -16% | 33.9% |
EXEL vs Sector: Exelixis has outperformed the "Healthcare" sector by 56.11% over the past year.
EXEL vs Market: Exelixis has outperformed the market by 6.3% over the past year.
Stable price: EXEL is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EXEL with weekly volatility of 0.7723% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (20.1 $) is higher than the fair price (6.81 $).
Price is higher than fair: The current price (20.1 $) is 66.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (37.04) is lower than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (37.04) is lower than that of the market as a whole (48.79).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.4) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (3.4) is higher than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.2) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (4.2) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (38.77) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (38.77) is higher than that of the market as a whole (28.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 17.17% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (17.17%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (123.79%).
5.4. ROE
ROE vs Sector: The company's ROE (9.18%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (9.18%) is lower than that of the market as a whole (10.82%).
5.5. ROA
ROA vs Sector: The company's ROA (7.06%) is higher than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (7.06%) is higher than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (13.59%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (13.59%) is higher than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5442%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 18.11.2024 | Haley Patrick J. Officer |
Purchase | 34.41 | 666 900 | 19 381 |
| 02.10.2024 | Haley Patrick J. EVP, Commercial |
Purchase | 24.41 | 2 441 000 | 100 000 |
| 01.10.2024 | MORRISSEY MICHAEL President and CEO |
Purchase | 24.41 | 11 716 800 | 480 000 |
| 23.09.2024 | Hessekiel Jeffrey EVP & General Counsel |
Sale | 26.38 | 659 500 | 25 000 |
| 26.08.2024 | Hessekiel Jeffrey EVP, General Counsel & Sec |
Sale | 25.79 | 515 800 | 20 000 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
